ETHZilla (ATNF) Stock Analysis
NASDAQHealthcareBiotechnology
What ETHZilla does
1180 Life Sciences Corp. is a biotechnology firm currently in the clinical trial phase, dedicated to creating treatments for pressing medical challenges including chronic pain, inflammation, fibrosis, and other related inflammatory conditions. The company's therapeutic pipeline is supported by three primary development platforms: An anti-tumor necrosis factor (anti-TNF) and fibrosis platform is progressing through Phase IIb clinical trials, specifically targeting fibrosis and anti-TNF pathways. A Synthetic Cannabidiol (CBD) Analogs platform, featuring laboratory-created derivatives of CBD, is currently in preclinical development. An a7nAChR platform, which functions as an immune suppressive agent by focusing on the alpha 7 nicotinic acetylcholine receptor, is also undergoing preclinical evaluation. Established in 2016, 1180 Life Sciences Corp. is based in Palo Alto, California.
Key metrics
ETFs linked to ATNF
Broad-market and Healthcare sector ETFs an investor holding ETHZilla is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how ATNF fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze ATNF in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for ETHZilla?
- ETHZilla trades under the ticker ATNF on NASDAQ.
- Which exchange is ATNF listed on?
- ATNF is listed on NASDAQ.
- What sector does ETHZilla operate in?
- ETHZilla is classified in the Healthcare sector (Biotechnology industry).
- How can PortView help analyze ATNF in a portfolio?
- PortView shows ATNF's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.